Risk of recurrence after cessation of dichoptic, binocular treatment of amblyopia.
Journal
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
ISSN: 1528-3933
Titre abrégé: J AAPOS
Pays: United States
ID NLM: 9710011
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
20
03
2023
revised:
09
06
2023
accepted:
16
06
2023
pmc-release:
01
10
2024
medline:
23
10
2023
pubmed:
25
8
2023
entrez:
24
8
2023
Statut:
ppublish
Résumé
Contrast-rebalanced dichoptic games and videos have been shown to be an effective treatment for childhood amblyopia. Whether the visual acuity gains achieved with these binocular treatments are long-lasting has not been determined. In this prospective cohort study of 100 consecutive amblyopic children who improved by ≥0.2 logMAR or obtained ≤0.2 logMAR amblyopic eye visual acuity during a binocular treatment clinical trial, risk of recurrence was 24% (95% CI, 16%-35%) at up to 3 years' follow-up according to Kaplan-Meier survival analysis, which accounts for censored, truncated, and missing data. Risk of recurrence was similar among children who required additional treatment for residual amblyopia after 4-8 weeks of dichoptic treatment (n = 62 [19%]; 95% CI, 10%-34%) and those who did not (n = 38 [32%]; 95% CI, 18%-52%; P = 0.12). There was no association between recurrence and age, visual acuity at the end of binocular treatment, stereoacuity, or ocular alignment. In a secondary analysis to compare rates of recurrence with published data, risk of recurrence in the subset of children who had no additional treatment for residual amblyopia (28%) was similar to the reported recurrence after cessation of successful patching and atropine (24%) at 12 months. Children with successful binocular treatment of amblyopia require monitoring for recurrence of amblyopia.
Identifiants
pubmed: 37619861
pii: S1091-8531(23)00175-1
doi: 10.1016/j.jaapos.2023.06.009
pmc: PMC10592044
mid: NIHMS1926660
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT04086524', 'NCT03288948', 'NCT02365090', 'NCT03825107']
Types de publication
Case Reports
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
298-300Subventions
Organisme : NEI NIH HHS
ID : R01 EY022313
Pays : United States
Informations de copyright
Copyright © 2023 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.
Références
JAMA Ophthalmol. 2015 Apr;133(4):479-80
pubmed: 25611129
J AAPOS. 2019 Jun;23(3):160.e1-160.e5
pubmed: 31103562
Ophthalmology. 2022 Jan;129(1):77-85
pubmed: 34534556
Optom Vis Sci. 2022 Mar 1;99(3):213-227
pubmed: 35086119
Prog Retin Eye Res. 2013 Mar;33:67-84
pubmed: 23201436
Sci Rep. 2022 Mar 9;12(1):4157
pubmed: 35264692
Optom Vis Sci. 2020 May;97(5):316-323
pubmed: 32413002
J AAPOS. 2004 Oct;8(5):420-8
pubmed: 15492733
BMJ Open Ophthalmol. 2022 May;7(1):
pubmed: 36161844